Integrated human/SARS-CoV-2 metabolic models present novel treatment strategies against COVID-19
Resumen: The coronavirus disease 2019 (COVID-19) pandemic caused by the new coronavirus (SARS-CoV-2) is currently responsible for more than 3 million deaths in 219 countries across the world and with more than 140 million cases. The absence of FDA-approved drugs against SARS-CoV-2 has highlighted an urgent need to design new drugs. We developed an integrated model of the human cell and SARS-CoV-2 to provide insight into the virus'' pathogenic mechanism and support current therapeutic strategies. We show the biochemical reactions required for the growth and general maintenance of the human cell, first, in its healthy state. We then demonstrate how the entry of SARS-CoV-2 into the human cell causes biochemical and structural changes, leading to a change of cell functions or cell death. A new computational method that predicts 20 unique reactions as drug targets from our models and provides a platform for future studies on viral entry inhibition, immune regulation, and drug optimisation strategies. The model is available in BioModels (https://www.ebi.ac.uk/biomodels/MODEL2007210001) and the software tool, findCPcli, that implements the computational method is available at https://github.com/findCP/findCPcli. © 2021 Bannerman et al.
Idioma: Inglés
DOI: 10.26508/LSA.202000954
Año: 2021
Publicado en: Life Science Alliance 4, 10 (2021), e202000954 [13p]
ISSN: 2575-1077

Factor impacto JCR: 5.781 (2021)
Categ. JCR: BIOLOGY rank: 17 / 94 = 0.181 (2021) - Q1 - T1
Factor impacto CITESCORE: 6.5 - Agricultural and Biological Sciences (Q1) - Environmental Science (Q1) - Biochemistry, Genetics and Molecular Biology (Q2)

Factor impacto SCIMAGO: 2.318 - Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q1) - Plant Science (Q1) - Ecology (Q1)

Tipo y forma: Article (Published version)
Área (Departamento): Área Lenguajes y Sistemas Inf. (Dpto. Informát.Ingenie.Sistms.)

Creative Commons You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.


Exportado de SIDERAL (2023-05-18-15:40:16)


Visitas y descargas

Este artículo se encuentra en las siguientes colecciones:
Articles



 Record created 2022-10-27, last modified 2023-05-19


Versión publicada:
 PDF
Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)